Which component is vital for the electronic submissions to be accepted by the FDA?

The submission of linked PDF files and SAS transport format datasets is the correct answer because these formats ensure that the electronic submissions meet the specific requirements set by the FDA for regulatory review. The FDA mandates that documentation submitted for drug applications must be in a structured and standardized format that allows for proper review, analysis, and storage.

SAS transport format is specifically designed for the interchange of datasets in clinical trials. It allows data to be shared across different systems while maintaining data integrity. Linked PDF files serve to present important documents, such as study protocols and reports, in a format that is both readable and accessible. Together, these components make electronic submissions compliant with the FDA's guidelines, ultimately facilitating a smoother review process.

The other provided options do not align with FDA submission requirements. In-person presentations are not a component of electronic submissions, and the use of Microsoft Word documents, while common in documentation, does not fulfill the regulatory standards required by the FDA for data submissions. Additionally, simply submitting clinical trial results without the proper formatting and structure would not be acceptable under the current FDA regulations.